UJ

Urmi Jayeshkumar Pandya

Active Director Designated Partner DIN 09016062
DIN 09016062 First appointment Dec 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Urmi Jayeshkumar Pandya

Data last updated:

Urmi Jayeshkumar Pandya is a Designated Partner at Urvas Pharmaceuticals Llp (since 2020). The company operates in Business Services.

DIN 09016062
Primary Designation Designated Partner
Industry Business Services
First Appointment 31 Dec 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner31 Dec 20202020Active

Board colleagues of Urmi Jayeshkumar Pandya

NameDINCompanyDesignation
Pritiben Maheshbhai Thaker09016083Urvas Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Urvas Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Urmi Jayeshkumar Pandya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmi Jayeshkumar Pandya

Urmi Jayeshkumar Pandya currently holds 1 directorship: Urvas Pharmaceuticals Llp (Designated Partner, since 31 Dec 2020).

Urmi Jayeshkumar Pandya was first appointed on 31 Dec 2020 as Designated Partner at Urvas Pharmaceuticals Llp.

The current boards of Urmi Jayeshkumar Pandya's companies include Pritiben Maheshbhai Thaker (Urvas Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available